fasudil has been researched along with Glomerulonephritis, Lupus in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, F | 1 |
| Huang, S | 1 |
| Xu, W | 1 |
| Xie, G | 1 |
| Gan, Y | 1 |
| Huang, F | 1 |
| Fan, Y | 1 |
| Bao, J | 1 |
1 other study available for fasudil and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
Fasudil compensates podocyte injury via CaMK4/Rho GTPases signal and actin cytoskeleton-dependent activation of YAP in MRL/lpr mice.
Topics: Actin Cytoskeleton; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Female; Lupus Nephr | 2023 |